Drug intelligence / Profile preview

Roxarsone

Development stage
Discontinued
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Roxarsone is an organoarsenic small molecule formerly used as a feed additive in poultry and swine to promote weight gain, improve feed efficiency, enhance pigmentation, and prevent coccidiosis by acting as a coccidiostat[1][5][7]. Its mechanism of action involves antibacterial activity and inhibition of protozoan parasites such as *Eimeria* species (coccidia)[2][5]. Roxarsone has also been shown to promote angiogenesis and glycolysis in animal models via induction of hypoxia-inducible factor-1α (HIF-1α), which may contribute to tumor growth[6]. The drug was marketed under the brand name 3-Nitro. Use of roxarsone has been discontinued or banned in many countries due to concerns about its metabolism into inorganic arsenic—a known toxin—in edible tissues[3][4][5].

Brand names
3-Nitro
Other names
4-hydroxy-3-nitrobenzenearsonic acidorganoarsenic compoundorganoarsonic acid
02

Targets

GSH (Glutathione)

Beyond the preview

Go deeper on Roxarsone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Roxarsone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call